Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:John_Sperzel
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:foundedYear |
2006
|
| gptkbp:founder |
gptkb:John_McDonough
gptkb:Garth_Rapeport gptkb:Jonathan_T._Soros gptkb:Tom_Lowery |
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
T2 Biosystems
|
| gptkbp:industry |
medical diagnostics
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:product |
gptkb:T2Bacteria_Panel
gptkb:T2Candida_Panel gptkb:T2Dx_Instrument gptkb:T2Resistance_Panel |
| gptkbp:publiclyTraded |
true
|
| gptkbp:specializesIn |
molecular diagnostics
sepsis detection |
| gptkbp:technology |
gptkb:T2_Magnetic_Resonance_(T2MR)
|
| gptkbp:tradedOn |
gptkb:NASDAQ:TTOO
|
| gptkbp:website |
https://www.t2biosystems.com/
|
| gptkbp:bfsParent |
gptkb:Langer,_Robert_S.
|
| gptkbp:bfsLayer |
5
|